Johan Lindbäck

7.7k citations

105 papers · 5.3k indexed · 3 hit papers · h-index 40

Impact in

Cardiology and Cardiovascular Medicine top 0.5%
- Acute Myocardial Infarction Research
- Atrial Fibrillation Management and Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
- Heart Failure Treatment and Management
- Cardiac Arrhythmias and Treatments
Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management

Papers in ⓘ

Cardiology and Cardiovascular Medicine 69
- Atrial Fibrillation Management and Outcomes 31
- Acute Myocardial Infarction Research 19
- Heart Failure Treatment and Management 18
- Antiplatelet Therapy and Cardiovascular Diseases 11
- Cardiac Arrhythmias and Treatments 8
Rheumatology 9
- GDF15 and Related Biomarkers 8

Co-authors: Lars Wallentin (55 shared papers)Ulf Stenestrand (22 shared papers)Stefan James (16 shared papers)Bo Lagerqvist (5 shared papers)Tage Nilsson (4 shared papers)Jonas Oldgren (30 shared papers)Ziad Hijazi (32 shared papers)Christopher B. Granger (26 shared papers)
Journals: Journal of the American College of Cardiology (13 papers)Journal of the American Heart Association (10 papers)European Heart Journal (10 papers)Circulation (6 papers)American Heart Journal (6 papers)
Partner nations: Sweden United States Canada

In The Last Decade

Johan Lindbäck

102 papers receiving 5.0k citations

Hit Papers

align trajectories log scale

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation 2016 · 284 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 European Heart Journal
2016 The Lancet
2007 New England Journal of Medicine

Peers

Countries citing papers authored by Johan Lindbäck

Since Specialization

Citations

This map shows the geographic impact of Johan Lindbäck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Lindbäck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Lindbäck more than expected).

Fields of papers citing papers by Johan Lindbäck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Lindbäck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Lindbäck. The network helps show where Johan Lindbäck may publish in the future.

Co-authors

The 25 scholars most cited alongside Johan Lindbäck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Johan Lindbäck Line = papers co-authored together Johan Lindbäck links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden New England Journal of Medicine ·Bo Lagerqvist, Stefan James, Ulf Stenestrand, Johan Lindbäck, Tage Nilsson, Lars Wallentin Hit paper breakdown →	2007	871
2	The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study The Lancet ·Ziad Hijazi, Jonas Oldgren, Johan Lindbäck, John H. Alexander, Stuart J. Connolly, John W. Eikelboom, Michael D. Ezekowitz, Claes Held, Elaine M. Hylek, Renato D. Lópes, Agneta Siegbahn, Salim Yusuf, Christopher B. Granger, Lars Wallentin Hit paper breakdown →	2016	330
3	The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation European Heart Journal ·Ziad Hijazi, Johan Lindbäck, John H. Alexander, Michael G. Hanna, Claes Held, Elaine M. Hylek, Renato D. Lópes, Jonas Oldgren, Agneta Siegbahn, Ralph Stewart, Harvey D. White, Christopher B. Granger, Lars Wallentin Hit paper breakdown →	2016	284
4	Influence of Renal Function on the Effects of Early Revascularization in Non-ST-Elevation Myocardial Infarction Circulation ·Karolina Szummer, Pia Lundman, Stefan H. Jacobson, Staffan Schön, Johan Lindbäck, Ulf Stenestrand, Lars Wallentin, Tomas Jernberg, (unknown)	2009	195
5	Long-term Outcome of Primary Percutaneous Coronary Intervention vs Prehospital and In-Hospital Thrombolysis for Patients With ST-Elevation Myocardial Infarction JAMA ·Ulf Stenestrand, Johan Lindbäck, Lars Wallentin, for the RIKS-HIA Registry	2006	194
6	Long-Term Safety and Efficacy of Drug-Eluting versus Bare-Metal Stents in Sweden New England Journal of Medicine ·Stefan James, Ulf Stenestrand, Johan Lindbäck, J. Carlsson, Fredrik Scherstén, Tage Nilsson, Lars Wallentin, Bo Lagerqvist	2009	178
7	Relation between renal function, presentation, use of therapies and in‐hospital complications in acute coronary syndrome: data from the SWEDEHEART register Journal of Internal Medicine ·Karolina Szummer, Pia Lundman, Stefan H. Jacobson, Staffan Schön, Johan Lindbäck, Ulf Stenestrand, Lars Wallentin, Tomas Jernberg, (unknown)	2009	131
8	Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission Heart ·Anna Norhammar, Johan Lindbäck, Lars Rydén, Lars Wallentin, Ulf Stenestrand	2007	127
9	The 2000 Tularemia Outbreak: A Case-Control Study of Risk Factors in Disease-Endemic and Emergent Areas, Sweden Emerging infectious diseases ·Henrik Eliasson, Johan Lindbäck, J. Pekka Nuorti, M Arneborn, Johan Giesecke, Anders Tegnell	2002	122
10	Stent Thrombosis in Sweden Circulation Cardiovascular Interventions ·Bo Lagerqvist, J. Carlsson, Ole Fröbert, Johan Lindbäck, Fredrik Scherstén, Ulf Stenestrand, Stefan James	2009	100
11	Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction European Heart Journal ·Erik Björklund, Ulf Stenestrand, Johan Lindbäck, Leif Svensson, Lars Wallentin, Bertil Lindahl	2006	97
12	Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non–ST-segment elevation acute coronary syndromes Journal of the American College of Cardiology ·Bertil Lindahl, Johan Lindbäck, Tomas Jernberg, Nina Johnston, Mats Stridsberg, Per Venge, Lars Wallentin	2005	92
13	A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score European Heart Journal ·Ziad Hijazi, Jonas Oldgren, Johan Lindbäck, John H. Alexander, Stuart J. Connolly, John W. Eikelboom, Michael D. Ezekowitz, Claes Held, Elaine M. Hylek, Renato D. Lópes, Salim Yusuf, Christopher B. Granger, Agneta Siegbahn, Lars Wallentin, (unknown)	2017	90
14	Troponin-T and N-Terminal Pro-B-Type Natriuretic Peptide Predict Mortality Benefit From Coronary Revascularization in Acute Coronary Syndromes Journal of the American College of Cardiology ·Stefan James, Johan Lindbäck, Johanna Tilly, Agneta Siegbahn, Per Venge, Paul W. Armstrong, Robert M. Califf, Maarten L. Simoons, Lars Wallentin, Bertil Lindahl	2006	87
15	Digoxin and mortality in atrial fibrillation: a prospective cohort study European Journal of Clinical Pharmacology ·Pär Hallberg, Johan Lindbäck, Bertil Lindahl, Ulf Stenestrand, Håkan Melhus, (unknown)	2007	86
16	Association between environmental risk factors and campylobacter infections in Sweden Epidemiology and Infection ·Karin Nygård, Yvonne Andersson, John-Arne Røttingen, Åke Svensson, Johan Lindbäck, Thomas Kistemann, Johan Giesecke	2004	82
17	Is the Increase in Notifications of Chlamydia trachomatis Infections in Sweden the Result of Changes in Prevalence, Sampling Frequency or Diagnostic Methods? Scandinavian Journal of Infectious Diseases ·Hannelore M Götz, Johan Lindbäck, Torvald Ripa, Kristina Ramstedt, Karl Ekdahl, M Arneborn	2002	81
18	The effect of azithromycin and Chlamydophilia pneumonia infection on expansion of small abdominal aortic aneurysms - A prospective randomized double-blind trial Journal of Vascular Surgery ·Lars Karlsson, Judy Gnarpe, David Bergqvist, Johan Lindbäck, Håkan Pärsson	2009	78
19	Biochemical indicators of cardiac and renal function in a healthy elderly population Clinical Biochemistry ·Nina Johnston, Tomas Jernberg, Bertil Lindahl, Johan Lindbäck, Mats Stridsberg, Anders Larsson, Per Venge, Lars Wallentin	2003	78
20	Differences in Restenosis Rate With Different Drug-Eluting Stents in Patients With and Without Diabetes Mellitus Journal of the American College of Cardiology ·Ole Fröbert, Bo Lagerqvist, J. Carlsson, Johan Lindbäck, Ulf Stenestrand, Stefan James	2009	78

About Johan Lindbäck

Johan Lindbäck is a scholar working on Cardiology and Cardiovascular Medicine, Rheumatology, Internal Medicine, Epidemiology and Infectious Diseases, having authored 105 papers that have together received 5.3k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (31 papers), Acute Myocardial Infarction Research (19 papers), Heart Failure Treatment and Management (18 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers), Cardiac Imaging and Diagnostics (9 papers), Cardiac Arrhythmias and Treatments (8 papers), GDF15 and Related Biomarkers (8 papers) and Coronary Interventions and Diagnostics (8 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (3.3k citations), Internal Medicine (309 citations), Surgery (1.7k citations), Radiology, Nuclear Medicine and Imaging (840 citations) and Nephrology (192 citations). Johan Lindbäck has collaborated with scholars based in Sweden, United States and Canada. Frequent co-authors include Lars Wallentin, Ulf Stenestrand, Stefan James, Bo Lagerqvist, Tage Nilsson, Jonas Oldgren, Ziad Hijazi, Christopher B. Granger, Renato D. Lópes and Agneta Siegbahn. Their work appears in journals such as Journal of the American College of Cardiology, Journal of the American Heart Association, European Heart Journal, Circulation and American Heart Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact